SCHEMBL7141809

SCHEMBL7141809

COc1cc(NC(=O)OC(C)(C)C)c(NC(=O)CC(=O)c2cccc(-n3ccnc3)c2)cc1-c1ccc(F)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.36
ADH5 P11766 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ABCB1 P08183 2/20 0.34
CYP3A4 P08684 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
KDM4D Q6B0I6 1/20 0.34
MAPK14 Q16539 1/20 0.34
BRD4 O60885 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705332 0.91 ABL1 (0.41) ABL1L3MBTL1ADH5MEN1KMT2A
SCHEMBL7147242 0.91 ABL1 (0.41) ABL1L3MBTL1ADH5MEN1KMT2A
SCHEMBL7143167 0.89 ABL1 (0.41) ABL1L3MBTL1MEN1KMT2AABCB1
SCHEMBL5868869 0.88 ADH5 (0.41) ABL1L3MBTL1ADH5KDM4DMAPK14
SCHEMBL7146597 0.88 ADH5 (0.41) ABL1L3MBTL1ADH5KDM4DMAPK14
SCHEMBL7139934 0.85 ABL1 (0.41) ABL1L3MBTL1ADH5KDM4DBRD4
SCHEMBL7145881 0.84 ABL1 (0.39) ABL1L3MBTL1ADH5ABCB1CYP3A4
SCHEMBL7139875 0.83 ABL1 (0.41) ABL1L3MBTL1CYP3A4KDM4DBRD4
SCHEMBL7140968 0.83 ABL1 (0.38) ABL1L3MBTL1ADH5CYP3A4ALDH1A1
SCHEMBL5868763 0.82 ABL1 (0.37) ABL1L3MBTL1ADH5KDM4DMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed